Human trials for coronavirus vaccine start in South Africa

By BBC On Tue, 23 Jun, 2020 17:15 | < 1 min read
Oxford University scientists, who are developing the COVID-19 vaccine said the drug has an 80 per cent chance of success, reports Sky News. [PHOTO | FILE]
The first doses of the vaccine are being administered in Johannesburg this week. PHOTO | FILE

Human trials for a Covid-19 vaccine developed by Oxford University are beginning in South Africa and in Brazil.

Some 2,000 people in South Africa will be involved in what is widely considered to be one of the earliest and most advanced trials for a vaccine to tackle the pandemic.

The first doses of the vaccine are being administered in Johannesburg this week.

South Africa has been chosen, not just for its expertise in this field, but because Covid-19 is now spreading fast here.

That makes it far easier for scientists to find a community at immediate risk of infection, and to then tell whether this British vaccine is effective.

Similar tests are already underway in the UK, but the infection rate there is slowing. Hence the move, not just to South Africa, but to Brazil too, where 5,000 people will be involved in the vaccine trial.

Are you a Kenyan in the diaspora with a story to tell? Do you know someone of Kenyan origin doing something remarkable in the diaspora? Do you have an opinion that you would like to share? Email us at [email protected]